(function(){
			var content_array=["<p><b>备注：本文是原文信息节选，详细报告内容详见<a href=\"https:\/\/t.prnasia.com\/t\/lIJr7TIr\" target=\"_blank\" rel=\"nofollow\" style=\"color: #0000FF\">www.eisai.com<\/a>。<\/b><\/p> \n<p><b>媒体联络：<\/b><\/p> \n<p><b>Eisai Co., Ltd.<br \/><\/b>Public Relations Department<br \/>TEL: +81 (0)3-3817-5120<\/p> \n<p><b>Eisai Europe, Ltd.<br \/><\/b>EMEA Communications Department<br \/>+44 (0) 797 487 9419<br \/><a href=\"https:\/\/t.prnasia.com\/t\/RS9giwLd\" target=\"_blank\" rel=\"nofollow\" style=\"color: #0000FF\">Emea-comms@eisai.net<\/a><\/p> \n<p><b>Eisai Inc. (U.S.)<br \/><\/b><span class=\"xn-person\">Libby Holman<\/span><br \/>+1-201-753-1945<br \/><a href=\"https:\/\/t.prnasia.com\/t\/ptP8TZBR\" target=\"_blank\" rel=\"nofollow\" style=\"color: #0000FF\">Libby_Holman@Eisai.com<\/a><\/p> \n<p><b>Biogen Inc.<br \/><\/b><span class=\"xn-person\">Madeleine Shin<\/span><br \/>+ 1-781-464-3260<br \/><a href=\"https:\/\/t.prnasia.com\/t\/RDeCGpTn\" target=\"_blank\" rel=\"nofollow\" style=\"color: #0000FF\">public.affairs@biogen.com<\/a><\/p> \n<p><b>投资人联络：<\/b><\/p> \n<p><b>Eisai Co., Ltd.<br \/><\/b>Investor Relations Department<br \/>TEL: +81 (0) 3-3817-5122<\/p> \n<p><b>Biogen Inc.<br \/><\/b><span class=\"xn-person\">Tim Power<\/span><br \/>+ 1-781-464-2442<br \/><a href=\"https:\/\/t.prnasia.com\/t\/Z5pYN6kX\" target=\"_blank\" rel=\"nofollow\" style=\"color: #0000FF\">IR@biogen.com<\/a><\/p> \n<p>&nbsp;<\/p>"];
			$("#dvExtra").html(content_array[0]);})();